Literature DB >> 6162195

Serological and physicochemical reactivity of bovine erythrocytes before and after trypsin treatment.

L Edebo, R R Coombs, R M Binns.   

Abstract

On partition in aqueous polymer two-phase systems containing dextran, poly(ethyleneglycol) (PEG), and PEG substituted with charged or hydrophobic groups "inagglutinable" ox erythrocytes showed more negative surface charge and less hydrophobicity than "agglutinable" ox erythrocytes. Tryspin treatment of the erythrocytes increased the agglutinability, reduced the negative charge, and seemed to increase the liability to hydrophobic interaction. Haemagglutination of highly negatively charged ox erythrocytes is almost impossible to accomplish by antibody against the ox erythrocytes alone or against IgG antigen linked to the erythrocytes in passive haemagglutination. Likewise, reverse passive (antiglobulin) haemagglutination cannot be accomplished with these cells when immunoglobulin antigens of moderate molecular size (less than or equal to 900,000) are used. However, these cells may be agglutinated when a non-charged carrier such as a bacterium coated with sensitizing antibody (immunoglobulin) is used to bridge the antiglobulin-coupled erythrocytes in a mixed latticer aggllutinate. Such a bridging can also be accomplished by heat aggregation of the immunoglobulin antigen.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6162195     DOI: 10.1111/j.1365-3083.1980.tb00059.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  2 in total

1.  Factors which govern the sensitivity of direct and indirect rosetting reactions and reverse passive haemagglutination in the identification of cell surface and free macromolecules.

Authors:  R M Binns; S T Licence; B W Gurner; R R Coombs
Journal:  Immunology       Date:  1982-12       Impact factor: 7.397

2.  Red-cell IgM-antibody capture assay for the detection of Mycoplasma pneumoniae-specific IgM.

Authors:  R R Coombs; G Easter; P Matejtschuk; T G Wreghitt
Journal:  Epidemiol Infect       Date:  1988-02       Impact factor: 2.451

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.